ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Refresh
01 Nov 2019 22:11

Korea Shorts Data Analysis (#1): Celltrion, Samsung Biologics, DS Infracore, HLB, & Hotel Shilla

This is our first inaugural edition of the Korea Shorts Data Analysis. We plan to make this into a regular piece. We broke down the Korean shorts...

Logo
373 Views
Share
24 Oct 2019 01:54

Celltrion Healthcare Block Deal Breakdown

5.5M shares are put up on the table again by One Equity. This represents 3.82% of SO. The ceiling is set at ₩55,000, a 7.09% discount to the last...

Logo
434 Views
Share
23 Oct 2019 17:02

Celltrion Healthcare Placement - None of the past Deals Have Done Well

One Equity Partners plans to raise US$258m via selling a third of its remaining stake in Celltrion Healthcare (091990 KS). This is the third...

Logo
482 Views
Share
21 May 2019 09:07

Celltrion H Block Deals Priced at Floor: More Short Entry Points Should Be On the Way

This block deal was another nice exit point for Celltrion H short sellers to wrap up short position. Just, 6.5M offering was simply massive, and...

Logo
586 Views
Share
20 May 2019 21:29

One Equity Partners Plans to Sell 4.5% Stake of Celltrion Healthcare

It was announced after market close today that One Equity Partners plans to sell 6.5 million shares (4.5% of shares outstanding) of Celltrion...

Logo
558 Views
Share
x